Analysts expect that Molina Healthcare (NYSE:MOH) will announce $4.72 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Molina Healthcare’s earnings. The highest sales estimate is $4.85 billion and the lowest is $4.64 billion. Molina Healthcare reported sales of $4.90 billion in the same quarter last year, which would suggest a negative year-over-year growth rate of 3.7%. The company is expected to report its next earnings results before the market opens on Monday, April 30th.
According to Zacks, analysts expect that Molina Healthcare will report full-year sales of $18.77 billion for the current fiscal year, with estimates ranging from $18.53 billion to $18.85 billion. For the next year, analysts anticipate that the company will post sales of $16.58 billion per share, with estimates ranging from $16.03 billion to $17.69 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that cover Molina Healthcare.
Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Monday, February 12th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.11. Molina Healthcare had a negative net margin of 2.58% and a positive return on equity of 17.64%. The business had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.96 billion.
Several analysts have issued reports on the stock. JPMorgan Chase upgraded shares of Molina Healthcare from a “neutral” rating to an “overweight” rating in a research report on Tuesday, January 16th. Leerink Swann upped their price target on shares of Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, January 9th. Morgan Stanley cut their price target on shares of Molina Healthcare from $97.00 to $94.00 and set an “overweight” rating for the company in a research report on Wednesday, February 7th. Goldman Sachs started coverage on shares of Molina Healthcare in a research note on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price objective for the company. Finally, Piper Jaffray upped their price objective on shares of Molina Healthcare to $92.00 and gave the company an “overweight” rating in a research note on Tuesday, March 20th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $78.86.
In related news, insider William Dentino sold 67,500 shares of the stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $86.71, for a total value of $5,852,925.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Terry Bayer sold 2,804 shares of the stock in a transaction dated Monday, January 22nd. The stock was sold at an average price of $91.63, for a total transaction of $256,930.52. Following the completion of the transaction, the chief operating officer now directly owns 70,092 shares of the company’s stock, valued at $6,422,529.96. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 298,474 shares of company stock valued at $25,245,712. Insiders own 0.65% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the stock. New Mexico Educational Retirement Board bought a new position in Molina Healthcare in the fourth quarter worth about $838,000. Boston Advisors LLC bought a new position in Molina Healthcare in the fourth quarter worth about $1,318,000. TCW Group Inc. bought a new position in Molina Healthcare in the fourth quarter worth about $30,407,000. Convergence Investment Partners LLC bought a new position in Molina Healthcare in the fourth quarter worth about $1,190,000. Finally, Jana Partners LLC raised its stake in Molina Healthcare by 52.5% in the third quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after buying an additional 731,992 shares in the last quarter.
NYSE MOH traded up $1.69 during trading on Wednesday, hitting $83.13. 835,569 shares of the company’s stock traded hands, compared to its average volume of 1,258,468. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.13. Molina Healthcare has a 12-month low of $47.07 and a 12-month high of $93.98. The firm has a market cap of $4,864.17, a price-to-earnings ratio of 148.45, a PEG ratio of 1.44 and a beta of 1.20.
TRADEMARK VIOLATION WARNING: “$4.72 Billion in Sales Expected for Molina Healthcare (MOH) This Quarter” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/16/4-72-billion-in-sales-expected-for-molina-healthcare-moh-this-quarter.html.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Get a free copy of the Zacks research report on Molina Healthcare (MOH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.